MergerLinks Header Logo

Submit Deal

Submit Deal

Announced

Completed

Børtind Invest completed the acquisition of a 90% stake in Medibrix from Fürst Medisinsk Laboratorium.

Synopsis

Børtind Invest, an investment company, completed the acquisition of a 90% stake in Medibrix, a healthcare software company, from Fürst Medisinsk Laboratorium, a private medical laboratory in Norway. Financial terms were not disclosed.

Principals

Medibrix (formerly Helseboka)

target

Medibrix (formerly Helseboka)

Bortind Invest As

bidder

Bortind Invest As

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2026 Datasite

MergerLinks - Børtind Invest completed the acquisition of a 90% stake in Medibrix from Fürst Medisinsk Laboratorium.